Trump’s Pick for Surgeon General Once Claimed Smoking Pot Leads to Enlarged Breasts in Men

The White House has tapped a new face for the Surgeon General spot, and if you are a fan of the plant, you might want to lean in for this one. President Trump recently nominated Nicole Saphier, a radiologist from the prestigious Memorial Sloan Kettering, to take on the role of "America's doctor." While she isn't the one making the final call on rescheduling, the Surgeon General has a massive megaphone when it comes to shaping how the public views health and wellness.

Saphier has a bit of a mixed track record with cannabis. On one hand, she has expressed some pretty old-school concerns, even claiming in the past that heavy use can lead to "man boobs" or gynecomastia. She’s also been vocal about her worries regarding high-potency products and how legalization might impact younger generations. For those of us who appreciate the craft and the culture, it’s a reminder that there’s still plenty of education to be done at the highest levels of government.

However, it’s not all "just say no" vibes. Saphier has actually acknowledged that medical cannabis has legitimate potential. She’s pointed to its effectiveness for folks dealing with chronic pain, MS, and nausea from chemo. She also seems much more comfortable with CBD, suggesting it’s a lower-risk alternative for people looking to step away from alcohol.

This news matters because as we move toward federal rescheduling, having a Surgeon General who recognizes medical value—even with a cautious eye—is a step forward from the total prohibitionist mindset of the past. For the everyday enthusiast, this is a great time to stay informed and keep advocating for responsible, adult-use access. While the "man boobs" comments might earn a few eye-rolls in the community, the shift toward acknowledging medical benefits is the real story here. Stay lifted and keep an eye on how these confirmation hearings unfold!